UnknownNot Applicable

Serologic Profile of SARS CoV2 in COVID-19 Patients With Systemic Diseases

Tunisia200 participantsStarted 2020-06-01

Plain-language summary

An observational study aiming to assess the serological profile of SARS-Cov2 patients with systemic diseases such as systemic lupus erythematosus, Sjogren syndrome, sarcoidosis, inflammatory myopathies, Behçet's disease, Rheumatoid arthritis and Spondyloarthritis

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age over 18 years old * One of the following conditions: systemic lupus, Sjögren's syndrome, rheumatoid arthritis, inflammatory myopathies, spondyloarthritis, sarcoidosis and Behçet's disease. * Informed consent obtained and signed Exclusion Criteria: * Refusal to repeat blood sampling if the first one was badly performed * Informed consent not obained

What they're measuring

Serological Profile

Timeframe: Inclusion

Trial details

NCT IDNCT04530461

Sponsorfaida agili

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2020-11-30

Contact for this trial

Faida Ajili, MD

+21698631188 faida1977@yahoo.fr

View on ClinicalTrials.gov More SARS-CoV Infection trials